logologo
Search anything
arrow
WhatsApp Icon

MCX Buy Call: Jefferies Targets Rs 3,600, +27%

What triggered the move in MCX

Multi Commodity Exchange of India (MCX) was in focus after Jefferies initiated coverage on the stock with a “buy” recommendation and a target price of Rs 3,600. Jefferies said the target implies an upside of 27% from the stock’s Tuesday close. The brokerage’s view landed at a time when Indian market-intermediary stocks have been swinging sharply amid regulatory and liquidity concerns.

In early trade following the note, MCX shares jumped more than 5% to Rs 2,983.90 on the NSE around 1311 IST. The stock rose to an intraday high of Rs 2,993 per share, and later gave up part of the gains due to profit booking. MCX eventually settled at Rs 2,963 per share, up 4.43% on the day.

Jefferies starts coverage with a Buy and Rs 3,600 target

Jefferies’ initiation sets a clear valuation framework for MCX. The brokerage set a price target of Rs 3,600 per share based on 45x Jun-28e EPS. The note also referenced the prior close of Rs 2,841 as the base for the implied 27% upside.

The report positions MCX as relatively better placed than some other exchange-linked plays that have been vulnerable to policy-related uncertainty. While the broader sector has seen quick sentiment shifts, Jefferies’ initiation gave investors a fresh set of reference points on profitability and product characteristics.

Why Jefferies sees MCX as more profitable than BSE

A central argument in Jefferies’ call is that MCX is “more profitable compared to BSE”. The brokerage attributed this to cost structure differences rather than near-term volume swings. Specifically, Jefferies pointed to MCX’s lower regulatory fees, which it linked to the exchange’s higher share of longer-dated contracts.

Jefferies also said MCX has no clearing charges, another factor supporting profitability versus BSE. The framing matters because, during periods of high activity, headline turnover can rise across exchanges, but the quality of earnings is influenced by fee structures, clearing costs, and the mix of products being traded.

The valuation gap versus BSE, and why Jefferies justifies it

Jefferies addressed the common comparison investors make between MCX and BSE. On valuation, the brokerage argued that MCX’s premium to domestic peer BSE is justified by its larger product scope, a longer penetration runway, and superior profitability metrics.

In the same context, the report referenced BSE being valued at 36x Jun-28e EPS. MCX, in contrast, is valued by Jefferies at 45x Jun-28e EPS for the purposes of its target. The message is that Jefferies sees a structural basis for the differential rather than treating it as a temporary market anomaly.

Broader backdrop: volatility across exchange-linked stocks

The initiation comes amid market volatility where exchange and broking names have moved sharply on policy headlines. The broader narrative cited rallies in Indian exchanges BSE and MCX driven by increased trading activity, with both reporting strong Q4 earnings. At the same time, brokerage stances have diverged, with Jefferies and ICICI Securities described as cautious on BSE due to stagnant market share, while other brokerages such as HDFC Securities and Morgan Stanley were described as more optimistic on MCX and its commodity trading growth drivers.

This split in views highlights how investors are separating “activity-led” boosts from structural drivers. In that framing, product depth, pricing, and profitability levers become more important than a single quarter’s momentum.

RBI’s collateral and funding overhaul adds another variable

Regulatory changes have also influenced how the market prices intermediaries. A Reserve Bank of India overhaul of collateral and funding norms is set to raise costs for proprietary traders while sparing most retail brokers, according to the provided context. Analysts warned that the tightening could lower liquidity and pressure earnings.

The sell-off following the announcement underscored sensitivity to funding and margin rules. Reports said shares of BSE, Angel One, MCX and Groww fell as analysts assessed the potential impact, with some names falling up to 10%. The new regulations are set to take effect April 1.

Competitive angle: NSE’s move into commodity derivatives

MCX’s longer-term narrative also intersects with competition in commodity derivatives. The provided context noted that the National Stock Exchange of India has made a serious move into commodity derivatives, which directly challenges MCX’s core franchise that has dominated commodity trading in India for years.

The competitive risk is straightforward: if a large rival exchange captures a portion of commodity trading volumes, MCX’s market position could weaken, revenue growth could slow, and pricing power could reduce. While the context did not quantify market share shifts, it underlines why brokerage notes on MCX often balance profitability strengths with evolving competitive dynamics.

Key facts and figures at a glance

ItemDetail
Brokerage actionJefferies initiated coverage on MCX with a Buy
Target priceRs 3,600
Implied upside27% from Tuesday close
Valuation basis cited45x Jun-28e EPS
Prior close referencedRs 2,841
MCX move after noteIntraday high Rs 2,993; closed Rs 2,963 (up 4.43%)
Mid-session referenceAround 1311 IST: about Rs 2,983.90 (over 5% up)
Peer comparison in noteBSE valued at 36x Jun-28e EPS

Market impact: what investors are likely tracking now

The immediate market impact was visible in MCX’s sharp move on the day Jefferies initiated coverage, including a more than 5% rise intraday and a 4.43% close. The note’s emphasis on lower regulatory fees and no clearing charges ties the investment case to margin structure and operating profitability rather than only to trading volumes.

At the same time, recent regulatory headlines, including RBI’s tighter collateral and funding norms effective April 1, have kept the entire market-intermediary basket sensitive to policy direction. For investors, the interplay between profitability drivers, trading activity, and regulatory cost changes remains central to how exchange valuations move in the short term.

What to watch next

Near-term attention is likely to remain on how trading activity holds up amid regulatory changes and whether liquidity conditions shift as RBI’s norms take effect. Investors will also track competitive developments in commodity derivatives as NSE expands in the segment.

For MCX specifically, the market will weigh Jefferies’ valuation framework and profitability rationale against the broader backdrop of policy-driven volatility in exchange and intermediary stocks.

Frequently Asked Questions

Jefferies initiated coverage on MCX with a Buy rating and a target price of Rs 3,600, implying about 27% upside from Tuesday’s closing level.
MCX rose more than 5% intraday to around Rs 2,983.90 and hit a high of Rs 2,993 before closing at Rs 2,963, up 4.43%.
Jefferies cited MCX’s lower regulatory fees due to a higher share of longer-dated contracts and the absence of clearing charges as key profitability drivers.
Jefferies set the Rs 3,600 target based on 45x Jun-28e EPS and compared it with BSE at 36x Jun-28e EPS.
The RBI’s overhaul of collateral and funding norms has raised concerns about higher costs for some participants, and the new regulations are set to take effect on April 1.

Did your stocks survive the war?

See what broke. See what stood.

Live Q4 Earnings Tracker